Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease
- 1 March 1984
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 15 (3) , 268-270
- https://doi.org/10.1002/ana.410150311
Abstract
A new heparinoid, Org 10172, was given to five patiens with hemorrhagic stroke with thromboembolic complications. Treatment did not cause progression of cerebral bleeding, and thrombotic processes were inhibited. No side effects were encountered.Keywords
This publication has 6 references indexed in Scilit:
- Effects of low-dose subcutaneous heparin on the occurrence of deep vein thrombosis in patients with ischemic strokeActa Neurologica Scandinavica, 2009
- USE OF A NEW HEPARINOID AS ANTICOAGULANT DURING ACUTE HAEMODIALYSIS OF PATIENTS WITH BLEEDING COMPLICATIONSThe Lancet, 1983
- A novel anti-thrombotic heparinoid (ORG 10172) devoid of bleeding inducing capacity: A survey of its pharmacological properties in experimental animal modelsThrombosis Research, 1982
- Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombinThrombosis Research, 1980
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980
- LOW-DOSE HEPARIN AS A PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER ACUTE STROKEThe Lancet, 1977